SCIEX Announces US HUPO Workshop: New Innovations Towards Industrialized Proteomics

SCIEX Seminars Will Focus on Using Industrialized Omics to Perform the Translational Research Needed to Enable Precision Medicine

March 11, 2016


SCIEX, a global leader in life science analytical technologies announced today an exciting precision medicine workshop to take place at US HUPO on "New Innovations Towards Industrialized Proteomics." Join representatives from SCIEX, Pressure Biosciences, Inc. (PBI) (OTCQB: PBIO), and Advaita Bioinformatics, as they share insightful examples of how SCIEX next-generation solutions are enabling life science researchers and scientists to unlock the potential of their discoveries using industrialized omics to enable precision medicine. The workshop will showcase examples of how SCIEX next-generation mass spec based solutions provide the ability to industrialize the omics research workflows.

Life Science researchers who are striving to transition from basic research to translational research will receive information about providing sample to biology solutions, accelerating and facilitating the biomarker research pipeline, from discovery, validation to translation into biologically and clinically relevant knowledge.

The workshop’s seminars include:

  • Next-generation Solutions to Industrialize Proteomics Studies and Advance Precision Medicine — Mark Cafazzo, Director of Academic Business at SCIEX leads a practical discussion on new technologies for enabling reproducible and biologically meaningful results from proteomics experiments across very large sample cohorts in effort to Industrialize Proteomics.
  • From PCT-HD to SWATH® Data Acquisition in Half a Day — Vera Gross, PH.D., Senior Scientist at Pressure Biosciences, Inc. presents Advances of quantitative SWATH®-MS technology with the new introduction of sample QC kits and sample preparation techniques.
  • Overview of iPathwayGuide for Next-Gen Proteomics — Andrew Olson, VP of Business Development at Advaita Corporation discusses a case study whereby a meta-analysis with RNAseq transcript data is aligned with next-gen proteomics data for biological pathway knowledge, a cloud-enabled bioinformatics platform known as iPathwayGuide.


Mark Cafazzo, Director Academic Business, SCIEX
Vera Gross, Ph.D., Senior Scientist, Pressure, Biosciences, Inc
Andrew Olson, VP of Business Development, Advaita Corporation


Tuesday, March 15, 2016
12:15 PM – 1:45 PM EST


Westin Waterfront Hotel
425 Summer Street, Boston, MA, Commonwealth C
An audio recording will be made available after the conference, please contact SCIEX’s media contact for access.

Media Contact

Reporters, editors, and analysts interested in schedule interviews can contact:
Patrick Farrell
Sniper Public Relations on Behalf of SCIEX


SCIEX helps to improve the world we live in by enabling scientists and laboratory analysts to find answers to the complex analytical challenges they face. The company's global leadership and world-class service and support in the capillary electrophoresis and liquid chromatography-mass spectrometry industry have made it a trusted partner to thousands of the scientists and lab analysts worldwide who are focused on basic research, drug discovery and development, food and environmental testing, forensics and clinical research.

With over 40 years of proven innovation, SCIEX excels by listening to and understanding the ever-evolving needs of its customers to develop reliable, sensitive and intuitive solutions that continue to redefine what is achievable in routine and complex analysis. For more information, please visit

SCIEX social: @SCIEXnewsLinkedIn, and Facebook.

Contact Information
Lulu VanZandt
Program Manager, Brand, Public Relations and Social Media, SCIEX
+1 (508) 383-7163
M: +1 (508) 782-9484

AB Sciex is operating as SCIEX.
© 2018 AB Sciex. The trademarks mentioned herein are the property of the AB Sciex Pte. Ltd. or their respective owners. AB Sciex™ is being used under license.

For research use only. Not for use in diagnostic procedures.